A recently announced international life sciences partnership between the National Horizons Centre and Shonan Health Innovation Park is aimed at developing links between the Tees Valley and Japan and cementing the Tees Valley region as a global hub for life sciences.

Featuring representatives from biopharma companies across the Tees Valley and Shonan Health Innovation Park (Shonan iPark), the event will offer an insight into opportunities to develop international links  and provide information on the funding and collaboration opportunities available. At the event we will also hear from speakers from CPI, FUJIFILM Diosynth Biotechnologies and Nevrargenics.

National Horizons Centre
The National Horizons Centre (NHC) is a £22m centre of excellence for the biosciences and healthcare sector. With research, partnerships and training at its core, the NHC brings together industry, academia, talent and world-class facilities to create real-world impact. Together with its partners, the NHC prides itself on discovering diseases earlier, developing novel treatments and delivering life-saving medicines quicker, safer and more affordably. With specialisms in disease-specific research, biomanufacturing and digital analytics and machine learning, the NHC works in an agile way to advance biosciences and healthcare research.

Shonan iPark
Shonan iPark brings together industry, academia and the public sector into a collaborative ecosystem to transform cutting edge research into impactful health solutions. The Shonan iPark, operated by a partnership under Takeda Pharmaceutical Company Limited and Mitsubishi Corp.-UBS Realty Inc. with the support from Mitsubishi Corporation, is based in the Shonan region of the Kanagawa Prefecture in the centre of Japan.